ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. The present invention provides means and methods for determining antibodies against homocitrulline containing proteins or carbamylated proteins/peptides (anti...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SHI, JING VAN VEELEN, PETRUS ANTONIUS TOES, REINALDUS EVERARDUS MARIA HUIZINGA, THOMAS WILLEM JOHANNES TROUW, LEENDERT ADRIANUS CERAMI, ANTHONY |
description | Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. The present invention provides means and methods for determining antibodies against homocitrulline containing proteins or carbamylated proteins/peptides (anti-Car P) for the classification of individuals suffering from or at risk of suffering from arthritis.
Il est décrit des anticorps anti-protéines citrullinées (ACPA) qui sont pertinents pour diagnostiquer larthrite et potentiellement réaliser la pathogenèse de larthrite Linvention concerne des moyens et des méthodes pour déterminer des anticorps dirigés contre des protéines contenant de lhomocitrulline ou des protéines carbamylées/peptides carbamylés (anti-Car P) pour établir un classement des personnes souffrant darthrite ou présentant des risques de souffrir de larthrite. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3067295C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3067295C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3067295C3</originalsourceid><addsrcrecordid>eNrjZLB39Avx1HV2DHJy9I30cQxxdVEICPIPcfX0UwDJOPm7eLoGA5kuCiEergpBnsHeCm7-QQqOQSEeQZ4hnsE8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSTe2dHYwMzcyNLU2ZiwCgDaqyl_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS</title><source>esp@cenet</source><creator>SHI, JING ; VAN VEELEN, PETRUS ANTONIUS ; TOES, REINALDUS EVERARDUS MARIA ; HUIZINGA, THOMAS WILLEM JOHANNES ; TROUW, LEENDERT ADRIANUS ; CERAMI, ANTHONY</creator><creatorcontrib>SHI, JING ; VAN VEELEN, PETRUS ANTONIUS ; TOES, REINALDUS EVERARDUS MARIA ; HUIZINGA, THOMAS WILLEM JOHANNES ; TROUW, LEENDERT ADRIANUS ; CERAMI, ANTHONY</creatorcontrib><description>Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. The present invention provides means and methods for determining antibodies against homocitrulline containing proteins or carbamylated proteins/peptides (anti-Car P) for the classification of individuals suffering from or at risk of suffering from arthritis.
Il est décrit des anticorps anti-protéines citrullinées (ACPA) qui sont pertinents pour diagnostiquer larthrite et potentiellement réaliser la pathogenèse de larthrite Linvention concerne des moyens et des méthodes pour déterminer des anticorps dirigés contre des protéines contenant de lhomocitrulline ou des protéines carbamylées/peptides carbamylés (anti-Car P) pour établir un classement des personnes souffrant darthrite ou présentant des risques de souffrir de larthrite.</description><language>eng ; fre</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220621&DB=EPODOC&CC=CA&NR=3067295C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220621&DB=EPODOC&CC=CA&NR=3067295C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHI, JING</creatorcontrib><creatorcontrib>VAN VEELEN, PETRUS ANTONIUS</creatorcontrib><creatorcontrib>TOES, REINALDUS EVERARDUS MARIA</creatorcontrib><creatorcontrib>HUIZINGA, THOMAS WILLEM JOHANNES</creatorcontrib><creatorcontrib>TROUW, LEENDERT ADRIANUS</creatorcontrib><creatorcontrib>CERAMI, ANTHONY</creatorcontrib><title>ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS</title><description>Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. The present invention provides means and methods for determining antibodies against homocitrulline containing proteins or carbamylated proteins/peptides (anti-Car P) for the classification of individuals suffering from or at risk of suffering from arthritis.
Il est décrit des anticorps anti-protéines citrullinées (ACPA) qui sont pertinents pour diagnostiquer larthrite et potentiellement réaliser la pathogenèse de larthrite Linvention concerne des moyens et des méthodes pour déterminer des anticorps dirigés contre des protéines contenant de lhomocitrulline ou des protéines carbamylées/peptides carbamylés (anti-Car P) pour établir un classement des personnes souffrant darthrite ou présentant des risques de souffrir de larthrite.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB39Avx1HV2DHJy9I30cQxxdVEICPIPcfX0UwDJOPm7eLoGA5kuCiEergpBnsHeCm7-QQqOQSEeQZ4hnsE8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSTe2dHYwMzcyNLU2ZiwCgDaqyl_</recordid><startdate>20220621</startdate><enddate>20220621</enddate><creator>SHI, JING</creator><creator>VAN VEELEN, PETRUS ANTONIUS</creator><creator>TOES, REINALDUS EVERARDUS MARIA</creator><creator>HUIZINGA, THOMAS WILLEM JOHANNES</creator><creator>TROUW, LEENDERT ADRIANUS</creator><creator>CERAMI, ANTHONY</creator><scope>EVB</scope></search><sort><creationdate>20220621</creationdate><title>ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS</title><author>SHI, JING ; VAN VEELEN, PETRUS ANTONIUS ; TOES, REINALDUS EVERARDUS MARIA ; HUIZINGA, THOMAS WILLEM JOHANNES ; TROUW, LEENDERT ADRIANUS ; CERAMI, ANTHONY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3067295C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SHI, JING</creatorcontrib><creatorcontrib>VAN VEELEN, PETRUS ANTONIUS</creatorcontrib><creatorcontrib>TOES, REINALDUS EVERARDUS MARIA</creatorcontrib><creatorcontrib>HUIZINGA, THOMAS WILLEM JOHANNES</creatorcontrib><creatorcontrib>TROUW, LEENDERT ADRIANUS</creatorcontrib><creatorcontrib>CERAMI, ANTHONY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHI, JING</au><au>VAN VEELEN, PETRUS ANTONIUS</au><au>TOES, REINALDUS EVERARDUS MARIA</au><au>HUIZINGA, THOMAS WILLEM JOHANNES</au><au>TROUW, LEENDERT ADRIANUS</au><au>CERAMI, ANTHONY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS</title><date>2022-06-21</date><risdate>2022</risdate><abstract>Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. The present invention provides means and methods for determining antibodies against homocitrulline containing proteins or carbamylated proteins/peptides (anti-Car P) for the classification of individuals suffering from or at risk of suffering from arthritis.
Il est décrit des anticorps anti-protéines citrullinées (ACPA) qui sont pertinents pour diagnostiquer larthrite et potentiellement réaliser la pathogenèse de larthrite Linvention concerne des moyens et des méthodes pour déterminer des anticorps dirigés contre des protéines contenant de lhomocitrulline ou des protéines carbamylées/peptides carbamylés (anti-Car P) pour établir un classement des personnes souffrant darthrite ou présentant des risques de souffrir de larthrite.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA3067295C |
source | esp@cenet |
subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
title | ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T08%3A36%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHI,%20JING&rft.date=2022-06-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3067295C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |